Xuejing Zheng1, Wence Wu2, Zhenguo Zhao1

  • 1Departments of Orthopedics, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Nanli, Panjiayuan, Chaoyang District, Beijing, 100021, China.

概括

在骨髓瘤 (OS) 中的新辅助化疗促进癌症干和改变瘤微环境 (TME). 这种治疗减少了抗瘤免疫细胞,影响治疗效果,并可能导致抗药性.